Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study

DOI zum Zitieren dieses Dokuments:: 10.5283/epub.1960

Wiegand, Johannes ; Buggisch, Peter ; Boecher, Wulf ; Zeuzem, Stefan ; Gelbmann, Cornelia M. ; Berg, Thomas ; Kauffmann, Wolfgang ; Kallinowski, Birgit ; Cornberg, Markus ; Jaeckel, Elmar ; Wedemeyer, Heiner ; Manns, Michael P.

PDF
(145kB) - Nur für Mitarbeiter des Archivs

Veröffentlichungsdatum dieses Volltextes: 05 Aug 2009 13:35

Alternative Links zum Volltext:DOI Pubmed Verlag

Details

Bibliographische Daten exportieren

Zusammenfassung

Early treatment of acute hepatitis C with interferon alpha-2b for 24 weeks prevents chronic infection in almost all patients. Because pegylated interferons have replaced conventional interferon in the therapy of chronic hepatitis C, the aim of this study was to analyze the efficacy of an early treatment of acute hepatitis C with peginterferon alpha-2b. Between February 2001 and February 2004, 89 ...